NASDAQ: COCH
Envoy Medical Inc Stock Forecast, Predictions & Price Target

Analyst price target for COCH

Based on 1 analyst offering 12 month price targets for Envoy Medical Inc

Min Forecast
$9.25+606.11%
Avg Forecast
$9.25+606.11%
Max Forecast
$9.25+606.11%

Should I buy or sell COCH stock?

Based on 1 analyst offering ratings for Envoy Medical Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their COCH stock forecasts and price targets.

COCH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-21

1 of 1

Forecast return on equity

Is COCH forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is COCH forecast to generate an efficient return on assets?

Company
-225.5%
Industry
9.53%
COCH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COCH earnings per share forecast

What is COCH's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.22

COCH revenue forecast

What is COCH's revenue in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$300.0k+33.33%

COCH vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
COCH$1.31$9.25+606.11%Buy
MDAI$1.18$3.50+196.61%Buy
RBOT$5.34$8.50+59.18%Hold
NXL$1.73$5.00+188.35%Strong Buy
NSYS$7.95N/AN/A

Envoy Medical Stock Forecast FAQ

Is Envoy Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: COCH) stock is to Buy COCH stock.

Out of 1 analyst, 0 (0%) are recommending COCH as a Strong Buy, 1 (100%) are recommending COCH as a Buy, 0 (0%) are recommending COCH as a Hold, 0 (0%) are recommending COCH as a Sell, and 0 (0%) are recommending COCH as a Strong Sell.

If you're new to stock investing, here's how to buy Envoy Medical stock.

What is COCH's earnings growth forecast for 2025-2025?

(NASDAQ: COCH) Envoy Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Envoy Medical's earnings in 2025 is -$27,973,000.

In 2025, COCH is forecast to generate -$26,018,475 in earnings, with the lowest earnings forecast at -$29,004,202 and the highest earnings forecast at -$24,525,612.

What is COCH's revenue growth forecast for 2025-2025?

(NASDAQ: COCH) Envoy Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Envoy Medical's revenue in 2025 is $225,000.

In 2025, COCH is forecast to generate $6,397,986 in revenue, with the lowest revenue forecast at $6,397,986 and the highest revenue forecast at $6,397,986.

What is COCH's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: COCH) forecast ROA is -225.5%, which is lower than the forecast US Medical Devices industry average of 9.53%.

What is COCH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year COCH price target, the average COCH price target is $9.25, with the highest COCH stock price forecast at $9.25 and the lowest COCH stock price forecast at $9.25.

The Wall Street analyst predicted that Envoy Medical's share price could reach $9.25 by Apr 21, 2026. The average Envoy Medical stock price prediction forecasts a potential upside of 606.11% from the current COCH share price of $1.31.

What is COCH's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: COCH) Envoy Medical's current Earnings Per Share (EPS) is -$1.49. In 2025, COCH's EPS is forecast to hit -$1.22 (min: -$1.36, max: -$1.15).

What is COCH's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: COCH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.